Conference: UKHSA 2025 | Manchester, UK | March 25-26, 2025 Seminar: ELISpot Resource Group | Munich, Germany | April 2, 2025 Seminar: ELISpot Resource Group | Oxford, United Kingdom | April 3, 2025 Congress: World Vaccine Congress | Washington DC, USA | April 21-24, 2025 ...
Conference: UKHSA 2025 | Manchester, UK | March 25-26, 2025 Seminar: ELISpot Resource Group | Munich, Germany | April 2, 2025 Seminar: ELISpot Resource Group | Oxford, United Kingdom | April 3, 2025 Congress: World Vaccine Congress | Washington DC, USA | April 21-24, 2025 ...
whether solid phase detection of complement-fixing donor-specific antibodies (DSA) has the potential to improve AMR prediction in high-risk transplants. The... G Bartel,M Wahrmann,E Schwaiger,... - 《Transplant International》 被引量: 19发表: 2013年 Deceased donor kidney transplantation across ...
Language-model-guided evolution could also complement or replace random mutagenesis strategies based on, for example, an error-prone polymerase. To the end user, guiding evolution via pre-trained, unsupervised models is less resource intensive than collecting enough task-specific data to train a ...
Davis WD, Brey RL: Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Rheumatol. 1992, 10: 455-460. CAS PubMed Google Scholar Brekke OH, Michaelsen TE, Sandlie I: The structural requirements for complement activation by IgG: does it hinge on the...
Their biological activities are characterised by a specific binding characteristic to a ligand (commonly known as antigen), and may be dependent on immune effector function such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC)....
A significant correlation with hypocomplementemia (C3 r = −0.37, p = 0.002 and C4 r = −0.32, p = 0.018) and anaemia (r = −0.32, p = 0.009). anti-dsDNA antibodies were detected in 35(53%) SLE patients; 70.8% of those with positive and 5.6% of those with negative anti-...
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in m... The efficacy of antibody-based immunotherapy is due to the activation of apoptosis, the engagement of antibody-dependent cellular cytotoxicity and comp...
Antibody mediated rejection (AMR) was assessed by histologic grading with hematoxylin and eosin (H&E) stains only until 2010 and thereafter a combination of H&E and immunohistochemical staining for complement deposition was performed [16], [17]. 2.5. Coronary Artery Vasculopathy The presence or ...
from small-intestinal mucosa [227]. Human mAbs against zika virus NS1 have also been generated by the single B cell method [228]. Besides mAbs for bacterial and virus infection, the single human B cell method has also yielded a complement factor H (CFH) therapeutic antibody for cancer. The...